Clinical Trial Results:
Standardized sTudy with Almotriptan in eaRly Treatment of migraine, START. An international, open-label, single arm, effectiveness and safety study of Almotriptan in primary care seeting.
Summary
|
|
EudraCT number |
2007-003392-39 |
Trial protocol |
FR IT |
Global completion date |
23 Mar 2009
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
02 Dec 2016
|
First version publication date |
18 Mar 2016
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
ALMO CL51 START CSR 20090709_Blackened |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.